BIZTRAC BETA
Retail sale of pharmaceutical products

ANTEVSKI AS

Org. no. 925979481 Limited company (AS) Kristiansand Incorporated 2020 Active
Ownership graph ↗
Operating profit NOK −65,000
Equity NOK 4.6m
Incorporated 2020
Share capital NOK 30,000

Signals

2 flags
  • Driftsunderskudd 2024 Siste driftsresultat er negativt (−65k kr).
  • Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

ANTEVSKI AS is registered as a limited company in Kristiansand, Agder with organisation number 925979481. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2020. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Investering og deltakelse i andre virksomheter. Selskapet kan videre delta i andre selskap gjennom aksjetegning eller annet samt driv handle med aksjer og verdipapirer, herunder lånefinasierte investeringer med verdipapirer og valuta.”.

Key figures · 2024

Operating profit
NOK −65,000
Equity
NOK 4.6m
Est. value
NOK 2.3m

Financial health · 2024

Liquidity
33.42
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
99.5%
Very good
Equity as a share of total capital

Who owns ANTEVSKI AS?

IVAN ANTEVSKI
ANTEVSKI AS
· NOK −65,000 profit

ANTEVSKI AS has 1 registered shareholder:

All shareholders and roles →

Which companies does ANTEVSKI AS own?

ANTEVSKI AS holds stakes in 2 companies:

See the full ownership structure →

Frequently asked questions about ANTEVSKI AS

Who owns ANTEVSKI AS?

IVAN ANTEVSKI is the largest registered owner, with 100.0%.

Who is the general manager of ANTEVSKI AS?

Ivan Antevski is registered as general manager of ANTEVSKI AS.

Where is ANTEVSKI AS based?

ANTEVSKI AS has its business address in Kristiansand S.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.